Stocks
Funds
Screener
Sectors
Watchlists
SENS

SENS - Senseonics Holdings Inc Stock Price, Fair Value and News

$0.47+0.03 (+6.82%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

SENS Price Action

Last 7 days

4.4%


Last 30 days

46.9%


Last 90 days

30.6%


Trailing 12 Months

-24.2%

SENS RSI Chart

SENS Valuation

Market Cap

278.5M

Price/Earnings (Trailing)

-3.47

Price/Sales (Trailing)

12.54

Price/Free Cashflow

-4.54

SENS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SENS Fundamentals

SENS Revenue

Revenue (TTM)

22.2M

Rev. Growth (Yr)

-30.08%

Rev. Growth (Qtr)

-12.37%

SENS Earnings

Earnings (TTM)

-80.3M

Earnings Growth (Yr)

0.53%

Earnings Growth (Qtr)

-18.18%

SENS Profitability

Return on Equity

467.6%

Return on Assets

-83.4%

Free Cashflow Yield

-22%

SENS Investor Care

Shares Dilution (1Y)

12.18%

Diluted EPS (TTM)

-0.13

SENS Alerts

  • 3 major insider buys recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202423.3M24.0M22.2M0
202318.0M18.5M19.9M22.4M
202213.3M13.7M14.8M16.4M
20217.8M10.8M13.6M13.7M
202017.2M13.1M9.0M4.9M
201919.4M20.4M19.5M21.3M
20188.8M11.6M14.6M18.9M
2017885.0K1.7M3.7M6.4M
2016077.0K91.0K365.0K
2015061.2K41.6K73.0K
20140000
SENS
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense, Eversense XL, and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
 CEO
 WEBSITEsenseonics.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES121

Senseonics Holdings Inc Frequently Asked Questions


What is the ticker symbol for Senseonics Holdings Inc? What does SENS stand for in stocks?

SENS is the stock ticker symbol of Senseonics Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Senseonics Holdings Inc (SENS)?

As of Fri Dec 20 2024, market cap of Senseonics Holdings Inc is 278.53 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SENS stock?

You can check SENS's fair value in chart for subscribers.

Is Senseonics Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether SENS is over valued or under valued. Whether Senseonics Holdings Inc is cheap or expensive depends on the assumptions which impact Senseonics Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SENS.

What is Senseonics Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, SENS's PE ratio (Price to Earnings) is -3.47 and Price to Sales (PS) ratio is 12.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SENS PE ratio will change depending on the future growth rate expectations of investors.